CDK12 IS A CONTEXT-SPECIFIC TUMORIGENESIS REGULATOR AND NOVEL THERAPEUTIC TARGET IN CASTRATION-RESISTANT PROSTATE CANCER.
$925,834FY2021Department of the ArmyDOD
Regents Of The University Of Michigan
Investigators
View source on USAspending →CDK12 IS A CONTEXT-SPECIFIC TUMORIGENESIS REGULATOR AND NOVEL THERAPEUTIC TARGET IN CASTRATION-RESISTANT PROSTATE CANCER. · GrantIndex